87 related articles for article (PubMed ID: 15240137)
21. The activation mechanism of chemokine receptor CCR5 involves common structural changes but a different network of interhelical interactions relative to rhodopsin.
Springael JY; de Poorter C; Deupi X; Van Durme J; Pardo L; Parmentier M
Cell Signal; 2007 Jul; 19(7):1446-56. PubMed ID: 17320349
[TBL] [Abstract][Full Text] [Related]
22. Protecting from R5-tropic HIV: individual and combined effectiveness of a hammerhead ribozyme and a single-chain Fv antibody that targets CCR5.
Cordelier P; Kulkowsky JW; Ko C; Matskevitch AA; McKee HJ; Rossi JJ; Bouhamdan M; Pomerantz RJ; Kari G; Strayer DS
Gene Ther; 2004 Nov; 11(22):1627-37. PubMed ID: 15295615
[TBL] [Abstract][Full Text] [Related]
23. Significance of N-terminal proteolysis of CCL14a to activity on the chemokine receptors CCR1 and CCR5 and the human cytomegalovirus-encoded chemokine receptor US28.
Richter R; Casarosa P; Ständker L; Münch J; Springael JY; Nijmeijer S; Forssmann WG; Vischer HF; Vakili J; Detheux M; Parmentier M; Leurs R; Smit MJ
J Immunol; 2009 Jul; 183(2):1229-37. PubMed ID: 19553544
[TBL] [Abstract][Full Text] [Related]
24. Hemofiltrate CC chemokines with unique biochemical properties: HCC-1/CCL14a and HCC-2/CCL15.
Forssmann U; Mägert HJ; Adermann K; Escher SE; Forssmann WG
J Leukoc Biol; 2001 Sep; 70(3):357-66. PubMed ID: 11527984
[TBL] [Abstract][Full Text] [Related]
25. A novel, selective, and orally available antagonist for CC chemokine receptor 3.
Morokata T; Suzuki K; Masunaga Y; Taguchi K; Morihira K; Sato I; Fujii M; Takizawa S; Torii Y; Yamamoto N; Kaneko M; Yamada T; Takahashi K; Shimizu Y
J Pharmacol Exp Ther; 2006 Apr; 317(1):244-50. PubMed ID: 16339911
[TBL] [Abstract][Full Text] [Related]
26. Leishmania major modulates chemokine and chemokine receptor expression by dendritic cells and affects their migratory capacity.
Steigerwald M; Moll H
Infect Immun; 2005 Apr; 73(4):2564-7. PubMed ID: 15784607
[TBL] [Abstract][Full Text] [Related]
27. MIP-1alpha utilizes both CCR1 and CCR5 to induce osteoclast formation and increase adhesion of myeloma cells to marrow stromal cells.
Oba Y; Lee JW; Ehrlich LA; Chung HY; Jelinek DF; Callander NS; Horuk R; Choi SJ; Roodman GD
Exp Hematol; 2005 Mar; 33(3):272-8. PubMed ID: 15730850
[TBL] [Abstract][Full Text] [Related]
28. Molecular characterization of a novel CC chemokine in large yellow croaker (Pseudosciaena crocea) and its involvement in modulation of MHC class I antigen processing and presentation pathway.
Zhang J; Chen X
Mol Immunol; 2008 Apr; 45(7):2076-86. PubMed ID: 18022238
[TBL] [Abstract][Full Text] [Related]
29. FROUNT is a common regulator of CCR2 and CCR5 signaling to control directional migration.
Toda E; Terashima Y; Sato T; Hirose K; Kanegasaki S; Matsushima K
J Immunol; 2009 Nov; 183(10):6387-94. PubMed ID: 19841162
[TBL] [Abstract][Full Text] [Related]
30. Specificity determinants for chemokine recognition identified using eotaxin-MCP-1 chimeras.
Mayer MR; Parody TR; Datta-Mannan A; Stone MJ
FEBS Lett; 2004 Jul; 571(1-3):166-70. PubMed ID: 15280036
[TBL] [Abstract][Full Text] [Related]
31. Chemokine expression is dysregulated in the endometrium of women using progestin-only contraceptives and correlates to elevated recruitment of distinct leukocyte populations.
Jones RL; Morison NB; Hannan NJ; Critchley HO; Salamonsen LA
Hum Reprod; 2005 Oct; 20(10):2724-35. PubMed ID: 15979999
[TBL] [Abstract][Full Text] [Related]
32. Analysis of second messenger pathways stimulated by different chemokines acting at the chemokine receptor CCR5.
Leach K; Charlton SJ; Strange PG
Biochem Pharmacol; 2007 Sep; 74(6):881-90. PubMed ID: 17645873
[TBL] [Abstract][Full Text] [Related]
33. TAK-652 inhibits CCR5-mediated human immunodeficiency virus type 1 infection in vitro and has favorable pharmacokinetics in humans.
Baba M; Takashima K; Miyake H; Kanzaki N; Teshima K; Wang X; Shiraishi M; Iizawa Y
Antimicrob Agents Chemother; 2005 Nov; 49(11):4584-91. PubMed ID: 16251299
[TBL] [Abstract][Full Text] [Related]
34. CC chemokines and chemokine receptors in IgA nephropathy (IgAN) and in non-IgA mesangial proliferative glomerulonephritis (MesProGN). the immunohistochemical comparative study.
Wagrowska-Danilewicz M; Danilewicz M; Stasikowska O
Pol J Pathol; 2005; 56(3):121-6. PubMed ID: 16334979
[TBL] [Abstract][Full Text] [Related]
35. CCR5 chemokine receptor mediates recruitment of MHC class II-positive Langerhans cells in the mouse corneal epithelium.
Yamagami S; Hamrah P; Miyamoto K; Miyazaki D; Dekaris I; Dawson T; Lu B; Gerard C; Dana MR
Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1201-7. PubMed ID: 15790880
[TBL] [Abstract][Full Text] [Related]
36. Alanine scanning mutagenesis of the chemokine receptor CCR3 reveals distinct extracellular residues involved in recognition of the eotaxin family of chemokines.
Duchesnes CE; Murphy PM; Williams TJ; Pease JE
Mol Immunol; 2006 Mar; 43(8):1221-31. PubMed ID: 16102831
[TBL] [Abstract][Full Text] [Related]
37. Overcoming HERG affinity in the discovery of the CCR5 antagonist maraviroc.
Price DA; Armour D; de Groot M; Leishman D; Napier C; Perros M; Stammen BL; Wood A
Bioorg Med Chem Lett; 2006 Sep; 16(17):4633-7. PubMed ID: 16782336
[TBL] [Abstract][Full Text] [Related]
38. Generation and properties of a human immunodeficiency virus type 1 isolate resistant to the small molecule CCR5 inhibitor, SCH-417690 (SCH-D).
Marozsan AJ; Kuhmann SE; Morgan T; Herrera C; Rivera-Troche E; Xu S; Baroudy BM; Strizki J; Moore JP
Virology; 2005 Jul; 338(1):182-99. PubMed ID: 15935415
[TBL] [Abstract][Full Text] [Related]
39. The solution structure of the anti-HIV chemokine vMIP-II.
Liwang AC; Wang ZX; Sun Y; Peiper SC; Liwang PJ
Protein Sci; 1999 Nov; 8(11):2270-80. PubMed ID: 10595530
[TBL] [Abstract][Full Text] [Related]
40. The N-terminal domain of CCL21 reconstitutes high affinity binding, G protein activation, and chemotactic activity, to the C-terminal domain of CCL19.
Ott TR; Lio FM; Olshefski D; Liu XJ; Ling N; Struthers RS
Biochem Biophys Res Commun; 2006 Sep; 348(3):1089-93. PubMed ID: 16904643
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
